Concepedia

Martin Siegemund

MS

Statistics

Publications

10

Citations

448

H-Index

10

Active since

2011

Affiliations

University of Stuttgart(Current)

Technische Universität Dresden

University of Tübingen

Stuttgart Technical University of Applied Sciences

Medizinische Hochschule Hannover

Martin Siegemund is an author at University of Stuttgart specializing in oncology, trail-mediated apoptosis, and death receptors.

ORCID

Publications per year

2011–2021

10

Publications

10

A TNF Receptor 2 Selective Agonist Rescues Human Neurons from Oxidative Stress-Induced Cell Death

Roman Fischer, Olaf Maier, Martin Siegemund et al. · PLoS ONE · 2011 · 126 citations · Full text

, , +17

Superior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivity

Martin Siegemund, Nadine Pollak, Oliver Seifert et al. · Cell Death and Disease · 2012 · 67 citations · Full text

, , +17

Increased Apoptosis Induction in Hepatocellular Carcinoma by a Novel Tumor-Targeted TRAIL Fusion Protein Combined With Bortezomib

Kristin Wahl, Martin Siegemund, Frank Lehner et al. · Hepatology · 2012 · 48 citations

, , +17

Tetravalent Antibody–scTRAIL Fusion Proteins with Improved Properties

Oliver Seifert, Aline Plappert, Sina Fellermeier et al. · Molecular Cancer Therapeutics · 2013 · 42 citations

, , +17

Superior Properties of Fc-comprising scTRAIL Fusion Proteins

Meike Hutt, Lisa Marquardt, Oliver Seifert et al. · Molecular Cancer Therapeutics · 2017 · 38 citations

, , +17

1–5 of 10